Molecular engineering of cholera toxin.
Burnette
W N
WN
Amgen Inc., Thousand Oaks, CA 91320, USA.
Kaslow
H R
HR
Moss
J
J
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000235:genetics; D002771:Cholera / Q000517:prevention & control; D002772:Cholera Toxin / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D022121:Cholera Vaccines / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D015394:Molecular Structure; D016297:Mutagenesis, Site-Directed; D011065:Poly(ADP-ribose) Polymerases / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D015202:Protein Engineering; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D010566:Virulence Factors, Bordetella / Q000737:chemistry / Q000235:genetics / Q000276:immunology
D000276:Adjuvants, Immunologic; D022121:Cholera Vaccines; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella; D002772:Cholera Toxin; D011065:Poly(ADP-ribose) Polymerases